PFOA: Lactational and Placental Transport Pharmacokinetic Study in Rats DuPont- 13309 Study Title PFOA: Lactational and Placental Transport Pharmacokinetic Study in Rats Laboratory Project ID: DuPont-13309 T-b8%1\ AUTHOR:Eve Mylchreest, Ph.D.

AR226-3584 p. 1 Andrea Y .

Enviroran ent En Arnnnemerd Canada Canada P. 1 5q 4 ~'` ~~C'~ ~ ~ Invitation to the Consultation Meeting Action Plan on Perfluorocarboxylic Acids and Precursors Invitation a la reunion de consultatio n Plan d'action pour les acides perfluorocarboxyliques et leurs precurseurs January 24, 2006 Le 24 janvier 200 6 Dear Sir or Madam, Madame, Monsieur , On December 20, 2005, you were sent a Nous vous avons envoye, le 20 decembre Consultation Notice for the Action Plan on 2005 dernier, un avis de consultation Perfluorocarboxylic Acids and Percursors . concernant un Plan d'action pour les acides Further to your interest in participating in perfluorocarboxyliques et leurs precurseurs . the consultation process, this letter is to Suite a votre interet a participer au processus confirm that the consultation meeting will de consultation, nous voulons confirmer que be held on Februa ry 6 and 7, 2006 at the la reunion de consultation aura lieu les 6 et 7 Holiday Inn Hotel in Ottawa.

P. 3M Center ~ St .

rer-is-zmon 11:47 sins pop loo FEE THE SOCIETY OF THE PLASTICS INDUSTRY, INC 1if <& PRUTZE rem . --_ FACSIMILE TRANSMITTAL SHEET 2i w wo KarenLannon /PamMoselw ey mow`:AllenC.Weiw dmanF/ =2 E EPA E 04/15/01 202.260.9555 a Sy -- 202.260.2797 1 Clarification of 4/13/01 FMG/EPA Ouacent Oroxneviey Drisasecomuent Dneaseasery OrieassRecvcis "Tmhis feuxisaintended to cltaherConifidfentyial Business Information (CBI) and non-CB MpraensuefnstcartuisoensrsasGrsouupb'sm(iFbtMyGt)TehtdeoSEocPiAetoynofFritdhaeyP,lAapsiecls1I3n,d2u0s0c1y,aInnca.ds(SpPrIe)sFelunotreotpdooElyPmAm.er 55 onMarch7,2001. 1.

CA ow --' genq_ 0501-0373 Vay 15,200 Fweensa-- Se Ar226- 1019 STG CGE LEetEE [Spon [ewe Jw il 1 SDocuomentnProceesingcCenotern(7407) SIM Cc iin senior toves P Niga ; yn 0:E9 Sg W0U1aSMshESinnvgieiroonrnmDe.nSCt.Wal2P0r4ot6e0ction Agency 8 BEHP-0- 37 mRe: rTSsCAHO8-61)1S3up0p.l3m7e5niSalEHnoi1f8o0r.S3u7l4f.oSnsEtQe .a0sd3a8nd1Car-SboEs0HyQl5i-c0.9b8a9s4.e3d:7F3lurochemicals Docket Dear Docket Coordinator: 5M recently complete analysesofseveral Toroshmicl compounds in ndividal, stored human sr.

ff BEHp-0103-1522 C33o1rpMoerdaitcealToDxeicpoalrotgyment S3tM PCaanlerI.

i2pf TELOMER RESEARCH PROGRAM 1200 SoTuathCHayses iSteeot cAtvingioon,e(Vipgnas212025050 AR 226 -- 127/ VF = Clariant QUIORD February 14, 2008 32 2 S3=R8= MarFy.

co If "WR Ls Rel PI " in o " DuPont Haskell Laboragy | Kar FYz-0500-/37 Tko- 060s NSforreTnavawcrooltogy soc and Industrial Medicine ' May2, 2000 Me.

PPFFOOAA::LLaactcattaitoinonaannddPPllaacceennttaallTTrraannssppoorrttPPhhaarrmmaaccookkiinneettiiccStdudyyiin RnatsRats____DDuuPpoonnt.1313330099 AR22b- 155 | ~ pos le lbeadoal al, ir " TRADPSECRET Gow Budenho LE Gl Gren Study Title PFOA: Lactational and Placental Transport Pharmacokinetic Study in Rats Laboratory Project ID: DuPont-13309 T6335.)

- BACK TO MAIN 3M Environmental Laboratory Report No.

Bladder Cancer inPerfluorooctanesulfonyl Fluoride Manufacturing Workers Final Report Bruce H.

AR226-2217 PJ!"

AR226-2280 , Privileged and Confidential Attorney Work Product-Prepared in Anticipation of Litigation Summary of Meeting with DAO 'Representatives April 24. 2002 Attendees: DuPont- Rob Pinchot Debbie Mulrooney Bob Ritchey Ann Bradley WVDEP-DAQ John Benedict Chris Arrington Dave Roberts WVDEP Dee Ann Staats Chris Negley (Office of Legal Services) Dave Watkins (Division of Water - Leader of G(ST) Debbie Mulrooney provided an overview of the air modeling report that was sent to DAQ on April 19, 2002.

DuPont Engineering July 22,2002 AR226-2590 OuPontEnginoBring BarieyMillB8!.